Alkem Laboratories (NSE:ALKEM) Other Stockholders Equity: ₹137,962 Mil (As of Mar. 2026)


NSE:ALKEM Alkem Laboratories Ltd NSE:ALKEM
98 GF Score
Price ₹5,669.50
GF Value ₹6,098.49
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Alkem Laboratories Other Stockholders Equity?

Alkem Laboratories NSE:ALKEM +0.37% 98 Other Stockholders Equity is ₹137,962 Mil as of Mar. 2026. GuruFocus rates NSE:ALKEM with a GF Score™ of 98/100 and a GF Value™ of ₹6,098.49 (Fairly Valued). The stock has 1 warning sign investors should review.

Alkem Laboratories's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹137,962 Mil.

Alkem Laboratories's quarterly Other Stockholders Equity declined from Sep. 2025 (₹133,221 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹137,962 Mil).

Alkem Laboratories's annual Other Stockholders Equity increased from Mar. 2024 (₹19,785 Mil) to Mar. 2025 (₹19,880 Mil) and increased from Mar. 2025 (₹19,880 Mil) to Mar. 2026 (₹137,962 Mil).

Alkem Laboratories Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Alkem Laboratories's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkem Laboratories Other Stockholders Equity Chart

Alkem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,201.00 19,694.10 19,784.50 19,879.50 137,961.90

Alkem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,879.50 0.00 133,220.70 0.00 137,961.90
NSE:ALKEM
98GF Score
Alkem Laboratories Ltd NSE:ALKEM
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkem Laboratories Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹137,962 Mil mean?
Alkem Laboratories (NSE:ALKEM) has a Other Stockholders Equity of ₹137,962 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Alkem Laboratories and its competitors.
Is Alkem Laboratories' Other Stockholders Equity too high?
Alkem Laboratories' current Other Stockholders Equity is ₹137,962 Mil. Overall, Alkem Laboratories has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alkem Laboratories' Other Stockholders Equity compare to ZTS and UTHR?
Alkem Laboratories' Other Stockholders Equity of ₹137,962 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Alkem Laboratories and its competitors. Alkem Laboratories's current Other Stockholders Equity is ₹137,962 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alkem Laboratories (NSE:ALKEM) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,098.49, compared to a current price of ₹5,669.50 — trading 7% below its estimated fair value. The current Other Stockholders Equity is ₹137,962 Mil. Alkem Laboratories' overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Alkem Laboratories (NSE:ALKEM), the current Other Stockholders Equity is ₹137,962 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkem Laboratories (NSE:ALKEM) Overvalued in 2026?

Based on GuruFocus' analysis, Alkem Laboratories stock appears to be undervalued. The current stock price of ₹5,669.50 is trading 7% below its estimated GF Value™ of ₹6,098.49. GuruFocus considers Alkem Laboratories to be Fairly Valued.

Key valuation signals for NSE:ALKEM:

  • Other Stockholders Equity: ₹137,962 Mil
  • GF Value™: ₹6,098.49 vs. price of ₹5,669.50 (7% below fair value)
  • GF Score™: 98/100 with 1 warning sign

No single metric tells the full story. See the NSE:ALKEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkem Laboratories Business Description

Other Exchanges 539523:India
Address Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
98GF Score

Get the complete analysis for NSE:ALKEM

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,669.50
Price
₹6,098.49
GF Value